Clinical Trials in San Antonio

Showing 3121-3140 of 12,572 trials

Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

NCT04508348

A clinical trial to evaluate length of stay, growth velocity and clinical outcomes in infants with neonatal abstinence syndrome receiving an exclusive human milk diet. Human milk is defined as expressed human milk or donor milk and its derivatives, human milk-based fortifier and human milk caloric fortifier.

Neonatal Abstinence Syndrome

The University of Texas Health Science Center at San Antonio19 participantsStarted Aug 2020

San Antonio, Texas, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

NCT03969212

Otherwise healthy index patients (IP) are randomized to either baloxavir marboxil or placebo if their influenza symptoms onset was within 48 hours of screening. Their households are enrolled within 24 hours of randomization if at least 1 household contacts (HHC) have not received influenza vaccine within 6 months of screening and if all HHC screen negative for influenza infection. The main endpoints are assessed based on multiple respiratory swabs, obtained from both IP and HHC up to 9 (+/-1) days post IP randomization, and through the assessment of symptoms.

Influenza

Hoffmann-La Roche4,138 participantsStarted Oct 2019

Birmingham, Alabama, United States • Pelham, Alabama, United States • Phoenix, Arizona, United States +139 more locations

Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet

Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households

Find Trials by Condition in San Antonio

Type of Exercise and Education in Patients With SubAcromial Pain Syndrome

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

rTMS for Stimulant Use Disorders

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

STEM-PD Open Label Extension (OLE)

Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL

Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

Abbott Vascular Medical Device Registry

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer